Jane Street Group LLC Has $574,000 Position in Boston Scientific Corporation (BSX)

Jane Street Group LLC trimmed its position in shares of Boston Scientific Corporation (NYSE:BSX) by 61.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,663 shares of the medical equipment provider’s stock after selling 30,767 shares during the quarter. Jane Street Group LLC’s holdings in Boston Scientific were worth $574,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Comerica Securities Inc. lifted its holdings in shares of Boston Scientific by 0.9% during the 2nd quarter. Comerica Securities Inc. now owns 11,478 shares of the medical equipment provider’s stock valued at $318,000 after buying an additional 99 shares during the period. ETRADE Capital Management LLC lifted its holdings in shares of Boston Scientific by 1.7% during the 2nd quarter. ETRADE Capital Management LLC now owns 10,079 shares of the medical equipment provider’s stock valued at $279,000 after buying an additional 171 shares during the period. Krilogy Financial LLC lifted its holdings in shares of Boston Scientific by 5.9% during the 2nd quarter. Krilogy Financial LLC now owns 7,680 shares of the medical equipment provider’s stock valued at $213,000 after buying an additional 430 shares during the period. Greenwood Capital Associates LLC lifted its holdings in shares of Boston Scientific by 1.1% during the 2nd quarter. Greenwood Capital Associates LLC now owns 53,330 shares of the medical equipment provider’s stock valued at $1,478,000 after buying an additional 564 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in shares of Boston Scientific by 0.6% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 101,738 shares of the medical equipment provider’s stock valued at $2,820,000 after buying an additional 596 shares during the period. 90.57% of the stock is currently owned by hedge funds and other institutional investors.

In other Boston Scientific news, EVP Timothy A. Pratt sold 10,000 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $26.04, for a total value of $260,400.00. Following the completion of the sale, the executive vice president now owns 154,681 shares in the company, valued at approximately $4,027,893.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael P. Phalen sold 15,500 shares of the stock in a transaction on Friday, September 29th. The stock was sold at an average price of $28.72, for a total value of $445,160.00. The disclosure for this sale can be found here. Insiders sold a total of 424,698 shares of company stock valued at $12,273,553 in the last quarter. 0.74% of the stock is currently owned by company insiders.

Boston Scientific Corporation (BSX) opened at $25.78 on Friday. Boston Scientific Corporation has a twelve month low of $21.29 and a twelve month high of $29.93. The company has a market capitalization of $35,401.00, a price-to-earnings ratio of 21.13, a P/E/G ratio of 1.99 and a beta of 0.96. The company has a quick ratio of 0.50, a current ratio of 0.72 and a debt-to-equity ratio of 0.58.

Boston Scientific (NYSE:BSX) last announced its earnings results on Thursday, October 26th. The medical equipment provider reported $0.31 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.31. Boston Scientific had a return on equity of 23.60% and a net margin of 9.55%. The company had revenue of $2.22 billion for the quarter, compared to analysts’ expectations of $2.21 billion. During the same period last year, the firm earned $0.27 EPS. Boston Scientific’s revenue for the quarter was up 5.6% compared to the same quarter last year. analysts anticipate that Boston Scientific Corporation will post 1.25 earnings per share for the current year.

BSX has been the topic of several research analyst reports. BidaskClub cut Boston Scientific from a “hold” rating to a “sell” rating in a report on Saturday, August 26th. BMO Capital Markets increased their price target on Boston Scientific from $30.00 to $32.00 and gave the company an “outperform” rating in a report on Friday, October 27th. Stifel Nicolaus reissued a “buy” rating and set a $32.00 price target on shares of Boston Scientific in a report on Monday, September 25th. SunTrust Banks set a $33.00 price target on Boston Scientific and gave the company a “buy” rating in a report on Monday, December 4th. Finally, Royal Bank of Canada reissued a “buy” rating and set a $31.00 price target on shares of Boston Scientific in a report on Friday, September 1st. One research analyst has rated the stock with a sell rating, four have issued a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. Boston Scientific has an average rating of “Buy” and an average target price of $31.03.

COPYRIGHT VIOLATION NOTICE: “Jane Street Group LLC Has $574,000 Position in Boston Scientific Corporation (BSX)” was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.com-unik.info/2017/12/17/jane-street-group-llc-has-574000-position-in-boston-scientific-corporation-bsx.html.

About Boston Scientific

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology.

Institutional Ownership by Quarter for Boston Scientific (NYSE:BSX)

What are top analysts saying about Boston Scientific? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Boston Scientific and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit